+ All Categories
Home > Documents > Assessment of immune function Management of patients with immunodeficiency disorders.

Assessment of immune function Management of patients with immunodeficiency disorders.

Date post: 23-Dec-2015
Category:
Upload: frederick-miles
View: 219 times
Download: 0 times
Share this document with a friend
Popular Tags:
39
Assessment of immune function Management of patients with immunodeficiency disorders
Transcript
Page 1: Assessment of immune function Management of patients with immunodeficiency disorders.

Assessment of immune function

Management of patients with immunodeficiency disorders

Page 2: Assessment of immune function Management of patients with immunodeficiency disorders.

Disorders of Immune System

• Defenses against infection

• Immune system disorders– Autoimmune diseases– Immunodeficiency

Page 3: Assessment of immune function Management of patients with immunodeficiency disorders.

Defenses Against Infection

• Barriers (non-specific)– Skin– Mechanical removal (coughing, vomiting,

diarrhea, skin sloughing)– Normal flora– Antimicrobial secretions

• Inflammation (non-specific)

• Immunity (specific)

Page 4: Assessment of immune function Management of patients with immunodeficiency disorders.

Immune Response

• Natural vs. Acquired

• Active vs. Passive

• Primary vs. Secondary

• Humoral vs. Cell-Mediated

Page 5: Assessment of immune function Management of patients with immunodeficiency disorders.

Humoral Immunity

• B Lymphocytes (Plasma Cells)– Produced in bone marrow

–Make antibodies (immunoglobulins)

Page 6: Assessment of immune function Management of patients with immunodeficiency disorders.

Antibodies

• Protein molecules produced by B-cells

• Specific shapes allow binding to specific molecules (antigens)

• Allow body to respond defensively to presence of specific potential threats

Page 7: Assessment of immune function Management of patients with immunodeficiency disorders.

Antibody Types

• IgG

• IgM

• IgA

• IgD

• IgE

Page 8: Assessment of immune function Management of patients with immunodeficiency disorders.

IgG

• Most common antibody type

• Only antibody that crosses placenta

• Prime mediator of secondary immune response

• Principal defender against bacteria, viruses, and toxins

Page 9: Assessment of immune function Management of patients with immunodeficiency disorders.

IgM

• Macroglobulin

• Confined to bloodstream

• First antibody to appear in response to presence of antigen

• Agent of primary immune response

Page 10: Assessment of immune function Management of patients with immunodeficiency disorders.

IgA

• Secretory antibody

• Found in saliva, tears, respiratory secretions, GI tract secretions

• Frontline bacterial, viral defense

Page 11: Assessment of immune function Management of patients with immunodeficiency disorders.

IgD

• Role not fully understood

• Low serum levels

• High concentrations on B-cells

• May act as receptors that trigger production of other antibodies

Page 12: Assessment of immune function Management of patients with immunodeficiency disorders.

IgE

• Very low serum levels

• Primarily bound to mast cells in tissues

• Controls allergic response

• Prevents parasitic infections

Page 13: Assessment of immune function Management of patients with immunodeficiency disorders.

Antigen-antibody binding initiates reactions that:• Neutralize bacterial toxins

• Neutralize viruses

• Promote phagocytosis

• Activate components of inflammatory response

Page 14: Assessment of immune function Management of patients with immunodeficiency disorders.

Cell-Mediated Immunity

• T Lymphocytes–Originate in bone marrow

–Altered by passage through thymus

–Responsible for mediation of cellular immunity

Page 15: Assessment of immune function Management of patients with immunodeficiency disorders.

T Lymphocyte Types

• Helper cells (T4 cells)

• Cytotoxic cells (Killer T cells)

• Suppressor cells

• Memory cells

Page 16: Assessment of immune function Management of patients with immunodeficiency disorders.

Helper T-Cells

• Master “on-switch” of immune system

• Recognize antigens

• Secrete lymphokines that activate all other immune system cells

• Stimulate B-cells to begin antibody production

Page 17: Assessment of immune function Management of patients with immunodeficiency disorders.

Cytotoxic (Killer) T-Cells

• Respond to presence of antigens and lymphokines produced by T-4 cells

• Seek out, bind to, and destroy:– Cells infected by viruses– Some tumor cells– Cells of tissue transplants

• Can deliver lethal hits on multiple cells in sequence

Page 18: Assessment of immune function Management of patients with immunodeficiency disorders.

Suppressor T-Cells

• Produce lymphokines that inhibit proliferation of B and T cells

• Downregulate or dampen immune response

Page 19: Assessment of immune function Management of patients with immunodeficiency disorders.

Memory T-Cells

• Have previously encountered specific antigens

• Respond in enhanced fashion on subsequent exposures

• Induce secondary immune response

Page 20: Assessment of immune function Management of patients with immunodeficiency disorders.

Inflammation• Occurs in vascularized tissue

• Nonspecific response to injury

• Response is same regardless of agent that initiates it

Page 21: Assessment of immune function Management of patients with immunodeficiency disorders.

Inflammation: Physiology

• Triggered by cellular injury

• Injury activates mast cells

• Mast cells release chemical mediators:– Histamine– Heparin– Leukotrienes (SRS-A)– Eosinophil chemotactic factor

Page 22: Assessment of immune function Management of patients with immunodeficiency disorders.

Inflammation: Pathology

• Mediators cause:– Vasodilation (redness, heat)– Vascular permeability (swelling)– White cell movement to and infiltration of

affected area (pus)– Nerve ending stimulation (pain)

“Dolor, Calor, Tumor, Rubor”

Page 23: Assessment of immune function Management of patients with immunodeficiency disorders.

Inflammation: Purposes

• Confines injurious agents

• Increases blood cell, plasma movement to injured areas

• Enhances immune response

• Destroys injurious agents

• Promotes healing

Page 24: Assessment of immune function Management of patients with immunodeficiency disorders.

Inflammation: Cellular Components

• Neutrophils– Phagocytic cells– Engulf foreign material/organisms– Arrive early– Short-lived

Page 25: Assessment of immune function Management of patients with immunodeficiency disorders.

Inflammation: Cellular Components• Macrophages– Phagocytic cells– Engulf foreign material/organisms– Arrive later– Long-lived– Transfer antigens back to T4 cells– Help initiate immune response to specific

agents

Page 26: Assessment of immune function Management of patients with immunodeficiency disorders.

Inflammation: Cellular Components

• Eosinophils– Secrete caustic proteins– Dissolve surface membranes of parasites

Page 27: Assessment of immune function Management of patients with immunodeficiency disorders.

Disorders of Immunity

Page 28: Assessment of immune function Management of patients with immunodeficiency disorders.

Autoimmune Disease

• Clinical disorder produced by an immune response to a normal tissue component of a patient’s body

Page 29: Assessment of immune function Management of patients with immunodeficiency disorders.

Autoimmune Diseases

• Hyperthyroidism

• Primary myxedema

• Type I diabetes

• Addison’s disease

• Multiple sclerosis

• Myasthenia gravis

Page 30: Assessment of immune function Management of patients with immunodeficiency disorders.

Autoimmune Diseases

• Rheumatic fever

• Crohn’s disease

• Ulcerative colitis

• Rheumatoid arthritis

• Systemic lupus erythematosis

Page 31: Assessment of immune function Management of patients with immunodeficiency disorders.

Systemic Lupus Erythematosis

• Primarily occurs in 20- to 40-year old females• Also in children and older adults• 90% of patients are female• Autoimmune reaction to host DNA• Mortality after diagnosis averages 5% per year

Page 32: Assessment of immune function Management of patients with immunodeficiency disorders.

Systemic Lupus Erythematosis

• Signs/Symptoms– Facial rash/skin rash

triggered by sunlight exposure

– Oral/nasopharyngeal ulcers

– Fever

– Arthritis

Page 33: Assessment of immune function Management of patients with immunodeficiency disorders.

Systemic Lupus Erythematosis

• Signs/Symptoms– Serositis (pleurisy, pericarditis)– Renal injury/failure– CNS involvement with

seizures/psychosis– Peripheral vasculitis/gangrene– Hemolytic anemia

Page 34: Assessment of immune function Management of patients with immunodeficiency disorders.

Systemic Lupus Erythematosis

• Chronic management– Anti-inflammatory drugs• Aspirin• Ibuprofen• Corticosteroids

–Avoidance of emotional stress, physical fatigue, excessive sun exposure

Page 35: Assessment of immune function Management of patients with immunodeficiency disorders.

Disorders of Immunity

Immunodeficiency Diseases

Page 36: Assessment of immune function Management of patients with immunodeficiency disorders.

Immunodeficiency Diseases

• Congenital

• Acquired

Page 37: Assessment of immune function Management of patients with immunodeficiency disorders.

Immunodeficiency Diseases: Congenital

• B cell deficiency– Agammaglobulinemia– Hypogammaglobulinemia

Page 38: Assessment of immune function Management of patients with immunodeficiency disorders.

Immunodeficiency Diseases: Congenital• T cell deficiency

• IgA deficiency

• Severe combined immune deficiency syndrome (B and T cell deficiency)

Page 39: Assessment of immune function Management of patients with immunodeficiency disorders.

Immunodeficiency Diseases: Acquired

• Nutritional deficiency

• Iatrogenic (drugs, radiation)

• Trauma (prolonged hypoperfusion)

• Stress

• Infection (AIDS)


Recommended